UnitedHealth Group reported strong second-quarter results with earnings and revenues exceeding year-over-year expectations. The increase in dividends and the renewal of the share repurchase program reflect managementâ€™s confidence, likely boosting investor sentiment in the short term despite some concerns about future margin pressures.

[1]